Crowdsourced identification of multi-target kinase inhibitors for RET- and TAU- based disease: the Multi-Targeting Drug DREAM Challenge
Z. Xiong, M. Jeon, R. J. Allaway, J. Kang, D. Park, J. Lee, H. Jeon, M. Ko, H. Jiang, M. Zheng, A. C. Tan, X. Guo, The Multi-Targeting Drug DREAM Challenge Community, K. K. Dang, A. Tropsha, , R. Cagan
The paper reports on a DREAM Challenge to predict multi-target kinase inhibitors for RET-based tumors and Tauopathy, using neural network-based machine learning approaches.
bioRxiv · Feb 15, 2021Pharmacology & Toxicology